De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D. Shi, William G. Kaelin, Jennifer E. Endress et al.|Cancer Cell|2022Cited by 132
De Novo Pyrimidine Synthesis is a Targetable Vulnerability in IDH Mutant GliomaDiana D. Shi, Samuel K. McBrayer, Milan R. Savani et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 11